2004 NEWS ARCHIVE
December 9, 2004
CPDR Researchers Awarded NIH R01 Funding for Cell Type-Specific Gene Expression Signature Research
The Center for Prostate Disease Research (CPDR) recently
received a four-year R01 grant from the National Institutes of Health
(NIH) to support a research project focusing on gene expression signatures
in benign and malignant epithelial and stromal cells of prostate cancer
patients with aggressive and non-aggressive disease.
Dr. Syed Shaheduzzamen
is a co-investigator on this project.
The funded project builds upon the pioneering work CPDR has long been doing to discover and learn the translational utility of genes commonly altered in human prostate cancer (CaP). The CPDR laboratory...
December 6, 2004
2004 Principal Investigators' Meeting
On December 2, 2004, CPDR hosted the annual Principal Investigators' Meeting at the East Jefferson site. CPDR Principal Investigators who attended the full day conference included Dr. John Ward of Naval Medical Center, Portsmouth, Dr. Trent Sterenchock from Eisenhower Army Medical Center, Ft. Gordon, Georgia, Dr. Christopher Amling from Naval Medical Center, San Diego, Dr. Keith O'Reilly from Madigan Army Medical Center, Dr. David McLeod from Walter Reed Army Medical Center and Dr. Christopher Porter from Virginia Mason Medical Center in Seattle. Dr. John Ward is an Associate Investigator who represented Dr. Leo Kusuda, Principal Investigator of Naval Medical Center Portsmouth. Other attendees included Dr. Shiv Srivastava, Dr. Rob Bienvenue, Ms. Pamela Harding, Ms. Marianne Spevak, Mr. Norbert Stingle, Ms. Stephanie Shaar, Mr. Jack Chang, Dr. Yongmei Chen, Ms. Michelle Zhao and Dr. Jennifer Cullen.
November 2, 2004
Johng Rhim, M.D., Wins Funding for Human Cell Model Research
Johng S. Rhim, M.D., Associate Director of CPDR and Director of the CPDR Prostate Cell Center, recently received notice from the Department of Defense Prostate Cancer Research Program (PCRP) that his project, "Development of a Human Cell Model for the Study of Familial Prostate Cancer," has been recommended for funding.
In cases of familial prostate cancer, the patient has one or more family members who have also been diagnosed with or show symptoms of the disease. Familial prostate cancer constitutes 9 percent of all prostate cancer cases. Dr. Rhim's project takes tumor specimens from such patients and generates in vitro cell lines, which are living, permanently propagating cells maintained and characterized in the laboratory. Ordinarily, primary tumor cells are able to reproduce through several cycles and then senesce, or die. The special value of Dr. Rhim's work ...
November 1, 2004
CPDR Database is featured in September issue of Oncology
Dr. Judd W. Moul, former CPDR Director and currently Professor and Chief, Division of Urologic Surgery, Duke University Medical Center, recently commented on an article in the September 2004 issue of Oncology (Moul, JW. The Cooperberg/Park/ Carroll Article Reviewed. Oncology. 2004 Sept. 18(2) 1248-1256).
The article "Prostate Cancer 2004: Insights from National Disease Registries" relates recent prostate cancer research from collaborations between various national prostate disease database efforts including CPDR, Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) and Harvard University.
In his review of the article, Dr. Moul discusses the usefulness of prostate-specific antigen (PSA) doubling time (the time it takes for the PSA ...
October 14, 2004
Dr. Jennifer Cullen is the newest addition to the staff at the East Jefferson site
Hired on October 4, 2004, she is already immersed in her role as Epidemiologist in our program and is working closely with the CPDR patient database, the Clinical Research Center at Walter Reed and the Institutional Review Board.
She hails from Havre de Grace, a small town near Baltimore, Maryland. While still young, she moved with her family to California due to her father's career change to the UCLA Cancer Center. In fact, her father was a major influence on her decision to specialize in the health sciences. He was Deputy Director of the National Cancer Institute for eight years, specializing in cancer prevention and control and even a close friend of Dr. C. Everett Koop, the former Surgeon General of the United States....
October 1, 2004
AFUD Honors Col David McLeod
On September 30, 2004, COL David McLeod was presented the Outstanding Service Award by the American Foundation of Urologic Disease (AFUD) at a gala evening event in Northwest Washington D.C. The reception, held at a historic mansion in the heart of the city, was attended by a wide variety of military and civilian guests gathered to honor McLeod, who is chief of urologic oncology and head of the urology residency program at Walter Reed Army Medical Center, for his contributions to the medical field. He is also interim director for the DoD Center for Prostate Disease Research (CPDR), which he co-founded in 1992, at the Uniformed Services University of the Health Sciences (USUHS). After five years as president of AFUD where he served with "vision and distinction" McLeod stepped down this year to devote more time to his patients, who admire him, wait in line for hours to see him and trust his care and treatment which he gears specifically to their age, health and disease stage.